<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="letter"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="publisher-id">JOACP</journal-id><journal-id journal-id-type="publisher-id">J Anaesthesiol Clin Pharmacol</journal-id><journal-title-group><journal-title>Journal of Anaesthesiology, Clinical Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0970-9185</issn><issn pub-type="epub">2231-2730</issn><publisher><publisher-name>Wolters Kluwer - Medknow</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9438837</article-id><article-id pub-id-type="publisher-id">JOACP-38-142</article-id><article-id pub-id-type="doi">10.4103/joacp.JOACP_486_20</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter to Editor</subject></subj-group></article-categories><title-group><article-title>Right ventricular dysfunction in COVID-19</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bhattacharyya</surname><given-names>Amrita</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Bhattacharjee</surname><given-names>Anirban</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Pande</surname><given-names>Aparna</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Baidya</surname><given-names>Dalim Kumar</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp"/></contrib></contrib-group><aff id="aff1">Department of Anesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India</aff><author-notes><corresp id="cor1">
<bold>Address for correspondence:</bold> Dr. Dalim Kumar Baidya, Department of Anesthesiology, Pain Medicine and Critical Care, Room No 5011, 5<sup>th</sup> Floor, Teaching Block, All India Institute of Medical Sciences, New Delhi - 110 029, India. E-mail: <email xlink:href="dalimkumar.ab8@gmail.com">dalimkumar.ab8@gmail.com</email>
</corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>30</day><month>6</month><year>2022</year></pub-date><volume>38</volume><issue>Suppl 1</issue><fpage>S142</fpage><lpage>S143</lpage><history><date date-type="received"><day>06</day><month>8</month><year>2020</year></date><date date-type="rev-recd"><day>14</day><month>4</month><year>2021</year></date><date date-type="accepted"><day>17</day><month>4</month><year>2021</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2022 Journal of Anaesthesiology Clinical Pharmacology</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions></article-meta></front><body><p>Dear Editor,</p><p>The COVID-19 pandemic has emerged as a global health emergency. Evidence has emerged regarding the affinity of the SARS CoV-2 virus for myocardial tissue and its propensity to cause myocardial damage. COVID-19 patients seem to be at increased risk of right heart dysfunction because of a) direct myocardial damage by the virus; and b) uncoupling of right ventricular-pulmonary arterial circulation as a result of hypoxia and altered lung mechanics.</p><p>In a series of 74 COVID-19 patients, Elsayed <italic toggle="yes">et al</italic>. found right ventricle (RV) dilatation in 41% and RV dysfunction in 27% of patients. In contrast, they found the left ventricle (LV) to be normal or hyperdynamic in the majority of patients.[<xref rid="R1" ref-type="bibr">1</xref>] Dweck <italic toggle="yes">et al</italic>.[<xref rid="R2" ref-type="bibr">2</xref>] performed a prospective survey on a large multi-center cohort of 1,216 patients and found evidence of LV dysfunction in 39% of the patients and RV dysfunction in 33% of the patients. In a study of 100 patients, Mahmoud-Szekely reported that the most common cardiac pathology detected on echocardiography was RV dilatation and dysfunction followed by LV dysfunction.[<xref rid="R3" ref-type="bibr">3</xref>]</p><p>From the available data, it is evident that RV dysfunction is as common as or more than LV dysfunction in these patients. Whether the RV dysfunction in COVID-19 patients is related to COVID-acute respiratory distress syndrome (ARDS) or a reflection of the viral disease process remains to be understood. However, as in non-COVID ARDS, the presence of RV dysfunction is associated with poor prognosis in COVID-19 too. Yuman Li and colleagues[<xref rid="R4" ref-type="bibr">4</xref>] in their study of 120 patients found that RV longitudinal strain as determined by RV speckle tracking echocardiography is an independent predictor of mortality. Similarly, Antonello D&#x02019;Andrea and colleagues[<xref rid="R5" ref-type="bibr">5</xref>] found RV dysfunction and raised pulmonary pressures independently correlated with a worse prognosis.</p><p>Trans-thoracic echocardiography (TTE) is a simple, easily available, and effective modality to detect and monitor RV dysfunction. Pulmonary artery catheters may be considered only in highly selected patients. RV protective strategies of mechanical ventilation like low driving pressure, limited hypercapnia, and optimum positive end-expiratory pressure (PEEP) may be helpful. Huette <italic toggle="yes">et al</italic>. have reported improvement in RV dysfunction in a patient with COVID-19 ARDS with almitrine infusion @4 mcg/kg/min, which facilitates hypoxic pulmonary vasoconstriction.[<xref rid="R6" ref-type="bibr">6</xref>] Significant improvement was observed within few hours, and it was continued for 4 days. However, almitrine may cause hepatic dysfunction and lactic acidosis. The FDA has recently granted emergency authorization to the right heart mechanical-assistive device Impella RP&#x000ae; system.[<xref rid="R7" ref-type="bibr">7</xref>] Extracorporeal membrane oxygenation (ECMO) remains the treatment option for nonresponding cases. The use of VV-ECMO is fraught with concerns regarding increased recirculation due to the decreased RV output and tricuspid regurgitation. Memon <italic toggle="yes">et al</italic>.[<xref rid="R8" ref-type="bibr">8</xref>] have reported the use of specialized Protek Duo cannula in association with VV-ECMO to reduce recirculation in a series of five patients. However, the availability of such specialized cannula remains an issue in this pandemic setting, and VA-ECMO may be preferred.</p><p>RV dysfunction is common but often under-recognized in COVID-19 patients. Early recognition with the help of TTE may help to titrate RV preload and afterload management with appropriate fluid and mechanical ventilation strategies.</p><sec disp-level="2"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec sec-type="COI-statement" disp-level="2"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></body><back><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Mahmoud-Elsayed</surname><given-names>HM</given-names></name>
<name><surname>Moody</surname><given-names>WE</given-names></name>
<name><surname>Bradlow</surname><given-names>WM</given-names></name>
<name><surname>Khan-Kheil</surname><given-names>AM</given-names></name>
<name><surname>Hudsmith</surname><given-names>LE</given-names></name>
<name><surname>Steeds</surname><given-names>RP</given-names></name>
</person-group><article-title>Echocardiographic findings in Covid-19 pneumonia</article-title><source>Can J Cardiol</source><year>2020</year><volume>36</volume><fpage>1203</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">32474111</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Dweck</surname><given-names>MR</given-names></name>
<name><surname>Bularga</surname><given-names>A</given-names></name>
<name><surname>Hahn</surname><given-names>RT</given-names></name>
<name><surname>Bing</surname><given-names>R</given-names></name>
<name><surname>Lee</surname><given-names>KK</given-names></name>
<name><surname>Chapman</surname><given-names>AR</given-names></name>
<etal/>
</person-group><article-title>Global evaluation of echocardiography in patients with COVID-19</article-title><source>Eur Heart J-Cardiovasc Imaging</source><year>2020</year><volume>21</volume><fpage>949</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">32556199</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Szekely</surname><given-names>Y</given-names></name>
<name><surname>Lichter</surname><given-names>Y</given-names></name>
<name><surname>Taieb</surname><given-names>P</given-names></name>
<name><surname>Banai</surname><given-names>A</given-names></name>
<name><surname>Hochstadt</surname><given-names>A</given-names></name>
<name><surname>Merdler</surname><given-names>I</given-names></name>
<etal/>
</person-group><article-title>Spectrum of cardiac manifestations in COVID-19: A systematic echocardiographic study</article-title><source>Circulation</source><year>2020</year><volume>142</volume><fpage>342</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">32469253</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>H</given-names></name>
<name><surname>Zhu</surname><given-names>S</given-names></name>
<name><surname>Xie</surname><given-names>Y</given-names></name>
<name><surname>Wang</surname><given-names>B</given-names></name>
<name><surname>He</surname><given-names>L</given-names></name>
<etal/>
</person-group><article-title>Prognostic value of right ventricular longitudinal strain in patients with COVID-19</article-title><source>JACC Cardiovasc Imaging</source><year>2020</year><volume>13</volume><fpage>2287</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">32654963</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>D&#x02019;Andrea</surname><given-names>A</given-names></name>
<name><surname>Scarafile</surname><given-names>R</given-names></name>
<name><surname>Riegler</surname><given-names>L</given-names></name>
<name><surname>Liccardo</surname><given-names>B</given-names></name>
<name><surname>Crescibene</surname><given-names>F</given-names></name>
<name><surname>Cocchia</surname><given-names>R</given-names></name>
<etal/>
</person-group><article-title>Right ventricular function and pulmonary pressures as independent predictors of survival in patients with COVID-19 pneumonia</article-title><source>JACC Cardiovasc Imaging</source><year>2020</year><volume>13</volume><fpage>2467</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">32654965</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Huette</surname><given-names>P</given-names></name>
<name><surname>Beyls</surname><given-names>C</given-names></name>
<name><surname>Guilbart</surname><given-names>M</given-names></name>
<name><surname>Haye</surname><given-names>G</given-names></name>
<name><surname>Najid</surname><given-names>F-Z</given-names></name>
<name><surname>Mestan</surname><given-names>B</given-names></name>
<etal/>
</person-group><article-title>Acute cor pulmonale in COVID-19-related ARDS: Improvement with almitrine infusion</article-title><source>JACC Case Rep</source><year>2020</year><volume>2</volume><fpage>1311</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">32835274</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="webpage" publication-format="web"><source>Health C for D and R. Other Medical Device EUAs. FDA 2020 Jul 8</source><comment>Available from: <uri xlink:href="https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/other-medical-device-euas">https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/other-medical-device-euas</uri></comment></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal" publication-format="print"><person-group person-group-type="author">
<name><surname>Memon</surname><given-names>HA</given-names></name>
<name><surname>Ratnani</surname><given-names>I</given-names></name>
<name><surname>Masud</surname><given-names>F</given-names></name>
</person-group><article-title>Extracorporeal Membrane Oxygenation Support Through Protek Duo Cannula: A Case Series</article-title><source>American Thoracic Society</source><year>2018</year><fpage>A5115</fpage><comment>(American Thoracic Society International Conference Abstracts)</comment></element-citation></ref></ref-list></back></article>
